1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Glycomic Therapeutics Market – By Class

1.3.2        Middle East & Africa Glycomic Therapeutics Market – By Structures

1.3.3        Middle East & Africa Glycomic Therapeutics Market – By Indications

1.3.4        Middle East & Africa Glycomic Therapeutics Market – By Mode of Action

1.3.5        Middle East & Africa Glycomic Therapeutics Market – By Country

2.           Middle East & Africa Glycomic Therapeutics Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Glycomic Therapeutics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa – PEST Analysis

4.3         Expert Opinion

5.           Middle East & Africa Glycomic Therapeutics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Wide Application in Various Disorders Followed by the Development of New Treatment Processes

5.1.2        Increasing Research and Development In the Field of Glycomic Therapeutics

5.2         Market Restraints

5.2.1        Shortage of Skilled Professionals and Lack of Research & Development laboratories in Developing Countries.

5.3         Market Opportunities

5.3.1        Wide Applications of Glycomics in Therapeutics

5.4         Future Trends

5.4.1        New Tools in Glycomics Research

5.5         Impact Analysis

6.           Glycomic Therapeutics Market– Middle East & Africa Analysis

6.1         Middle East & Africa Glycomic Therapeutics Market Revenue Forecast and Analysis

6.1.1        Middle East & Africa : Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million)

7.           Middle East & Africa Glycomic Therapeutics Market Revenue and Forecast to 2028– by Class

7.1         Overview

7.2         Middle East & Africa Glycomic Therapeutics Market, By Class 2022 & 2028 (%)

7.2.1        Middle East & Africa: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

7.3         Isolated

7.3.1        Overview

7.3.2        Middle East & Africa Isolated Revenue and Forecast to 2028 (US$ Million)

7.4         Synthetic

7.4.1        Overview

7.4.2        Middle East & Africa Synthetic - Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Glycomics Therapeutics Market Analysis and Forecasts To 2028 – By Indication

8.1         Overview

8.2         Middle East & Africa Glycomics Market, By Indication 2022 & 2028 (%)

8.2.1        Middle East & Africa: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

8.3         Thrombosis and Chemoprophylaxis

8.3.1        Overview

8.3.2        Middle East & Africa Thrombosis and chemoprophylaxis Revenue and Forecast to 2028 (US$ Million)

8.4         Anaemia

8.4.1        Overview

8.4.2        Middle East & Africa Anaemia Revenue and Forecast to 2028 (US$ Million)

8.5         Anti-adhesive and Anti-inflammatory

8.5.1        Overview

8.5.2        Middle East & Africa Anti-adhesive and Anti-inflammatory Revenue and Forecast to 2028 (US$ Million)

8.6         Cataract

8.6.1        Overview

8.6.2        Middle East & Africa Cataract Revenue and Forecast to 2028 (US$ Million)

8.7         Gaucher’s diseases

8.7.1        Overview

8.7.2        Middle East & Africa Gaucher’s diseases Revenue and Forecast to 2028 (US$ Million)

8.8         MPS-1 & IV

8.8.1        Overview

8.8.2        Middle East & Africa MPS-1 & IV Revenue and Forecast to 2028 (US$ Million)

8.9         Cancer

8.9.1        Overview

8.9.2        Middle East & Africa Cancer Revenue and Forecast to 2028 (US$ Million)

8.10      Alzheimer's

8.10.1     Overview

8.10.2     Middle East & Africa Alzheimer's Revenue and Forecast to 2028 (US$ Million)

8.11      Influenza Type A and B

8.11.1     Overview

8.11.2     Middle East & Africa Influenza Type A and B Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     Middle East & Africa Others Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Structures

9.1         Overview

9.2         Middle East & Africa Glycomic Therapeutics Market, By Structures 2022 & 2028 (%)

9.2.1        Middle East & Africa: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

9.2.1.1          Middle East & Africa: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

9.2.1.2          Middle East & Africa: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

9.2.1.3          Middle East & Africa: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

9.2.1.4          Middle East & Africa: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

9.3         Glycoproteins

9.3.1        Overview

9.3.2        Middle East & Africa Glycoproteins - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Targeting Sialic Acid

9.4.1        Overview

9.4.2        Middle East & Africa Targeting Sialic Acid - Market Revenue and Forecast to 2028 (US$ Million)

9.4.3        Zanamivir

9.4.3.1          Overview

9.4.3.2          Middle East & Africa Zanamivir - Market Revenue and Forecast to 2028 (US$ Million)

9.4.4        Oseltamivir

9.4.4.1          Overview

9.4.4.2          Middle East & Africa Oseltamivir - Market Revenue and Forecast to 2028 (US$ Million)

9.5         Proteoglycans

9.5.1        Overview

9.5.2        Middle East & Africa Proteoglycans - Market Revenue and Forecast to 2028 (US$ Million)

9.6         Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans

9.6.1        Overview

9.6.2        Middle East & Africa Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecast to 2028 (US$ Million)

9.7         Targeting Glycosaminoglycans

9.7.1        Overview

9.7.2        Middle East & Africa Targeting Glycosaminoglycans - Market Revenue and Forecast to 2028 (US$ Million)

9.7.3        Heparin

9.7.3.1          Overview

9.7.3.2          Middle East & Africa Heparin - Market Revenue and Forecast to 2028 (US$ Million)

9.7.4        Hyaluronan (HA)

9.7.4.1          Overview

9.7.4.2          Middle East & Africa Hyaluronan (HA)- Market Revenue and Forecast to 2028 (US$ Million)

9.7.5        Laronidase

9.7.5.1          Overview

9.7.5.2          Middle East & Africa Laronidase - Market Revenue and Forecast to 2028 (US$ Million)

9.7.6        Galsulfase (Naglazyme)

9.7.6.1          Overview

9.7.6.2          Middle East & Africa Galsulfase (Naglazyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.7.7        Hyaluronidase (Cumulase)

9.7.7.1          Overview

9.7.7.2          Middle East & Africa Hyaluronidase (Cumulase) - Market Revenue and Forecast to 2028 (US$ Million)

9.7.8        Others

9.7.8.1          Overview

9.7.8.2          Middle East & Africa Others - Market Revenue and Forecast to 2028 (US$ Million)

9.8         Targeting Glycosphingolipids

9.8.1        Overview

9.8.2        Middle East & Africa Targeting Glycosphingolipids - Market Revenue and Forecast to 2028 (US$ Million)

9.8.3        Imiglucerase (Cerezyme)

9.8.3.1          Overview

9.8.3.2          Middle East & Africa Imiglucerase (Cerezyme)- Market Revenue and Forecast to 2028 (US$ Million)

9.8.3.3          Agalsidase (Fabrazyme)

9.8.3.3.1          Overview

9.8.3.3.2          Middle East & Africa Agalsidase (Fabrazyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.8.3.4          N-butyl-deoxynojirimycin (DNJ)

9.8.3.4.1          Overview

9.8.3.4.2          Middle East & Africa N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecast to 2028 (US$ Million)

9.8.4        Others

9.8.4.1          Overview

9.8.4.2          Middle East & Africa Others - Market Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        Middle East & Africa Others - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3        Acarbose

9.9.3.1          Overview

9.9.3.2          Middle East & Africa Acarbose - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3.3          Alglucosidase Alfa (Myozyme)

9.9.3.3.1          Overview

9.9.3.3.2          Middle East & Africa Alglucosidase Alfa (Myozyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3.4          Allosamidin

9.9.3.4.1          Overview

9.9.3.4.2          Middle East & Africa Allosamidin - Market Revenue and Forecast to 2028 (US$ Million)

9.9.4        Others

9.9.4.1          Overview

9.9.4.2          Middle East & Africa Others - Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Mode of Action

10.1      Overview

10.2      Middle East & Africa Glycomic Therapeutics Market, By Mode of Action 2022 & 2028 (%)

10.2.1     Middle East & Africa: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

10.3      Inhibits Neuraminidase

10.3.1     Overview

10.3.2     Middle East & Africa Inhibits Neuraminidase - Market Revenue and Forecast to 2028 (US$ Million)

10.4      Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate

10.4.1     Overview

10.4.2     Middle East & Africa Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecast to 2028 (US$ Million)

10.5      Erythropoietin And Enzyme Replacement Therapy (ERT)

10.5.1     Overview

10.5.2     Middle East & Africa Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecast to 2028 (US$ Million)

10.6      Tissue Plasminogen Activator

10.6.1     Overview

10.6.2     Middle East & Africa Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)

10.7      Inhibits Glucosylceramide Synthase

10.7.1     Overview

10.7.2     Middle East & Africa Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)

10.8      Interleukin 1 And 2 And 3

10.8.1     Overview

10.8.2     Middle East & Africa Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)

10.9      Beta And Gamma Interferons

10.9.1     Overview

10.9.2     Middle East & Africa Beta And Gamma Interferons- Market Revenue And Forecasts To 2028 (US$ Million)

10.10   Others

10.10.1  Overview

10.10.2  Middle East & Africa Others- Market Revenue And Forecasts To 2028 (US$ Million)

11.        Middle East & Africa Glycomic Therapeutics Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Middle East & Africa: Glycomic Therapeutics Market

11.1.1     Overview

11.1.2     Middle East & Africa: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)

11.1.2.1       Saudi Arabia: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.2.1.1       Overview

11.1.2.1.2       Saudi Arabia: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.3       Saudi Arabia: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.2.1.4       Saudi Arabia: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.2.1.4.1    Saudi Arabia: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.2.1.4.2    Saudi Arabia: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.2.1.4.3    Saudi Arabia: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.2.1.4.4    Saudi Arabia: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.2.1.5       Saudi Arabia: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.2.1.6       Saudi Arabia: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

11.1.2.2       UAE: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.2.2.1       Overview

11.1.2.2.2       UAE: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.3       UAE: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.2.2.4       UAE: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.2.2.4.1    UAE: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.2.2.4.2    UAE: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.2.2.4.3    UAE: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.2.2.4.4    UAE: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.2.2.5       UAE: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.2.2.6       UAE: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

11.1.2.3       South Africa: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.2.3.1       Overview

11.1.2.3.2       South Africa: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.3       South Africa: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.2.3.4       South Africa: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.2.3.4.1    South Africa: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.2.3.4.2    South Africa: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.2.3.4.3    South Africa: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.2.3.4.4    South Africa: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.2.3.5       South Africa: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.2.3.6       South Africa: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

11.1.2.4       Rest of Middle East and Africa: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

11.1.2.4.1       Overview

11.1.2.4.2       Rest of MEA: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.4.3       Rest of MEA: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.2.4.4       Rest of MEA: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.2.4.4.1    Rest of MEA: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.2.4.4.2    Rest of MEA: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.2.4.4.3    Rest of MEA: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.2.4.4.4    Rest of MEA: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.2.4.5       Rest of MEA: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.2.4.6       Rest of MEA: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

12.        Middle East & Africa Glycomic Therapeutics Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Glycomic Therapeutics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      Protalix Biotherapeutics

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      BioMarin Pharmaceutical Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Genzyme Corporation (Sanofi)

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bayer AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      F. Hoffmann-La Roche Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms in Glycomic Therapeutics Market

LIST OF TABLES

Table 1.             Middle East & Africa: Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million).

Table 2.             Middle East & Africa Glycomic Therapeutics Market, by C lass – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Middle East & Africa Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4.             Middle East & Africa Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)

Table 5.             Middle East & Africa Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)

Table 6.             Middle East & Africa Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)

Table 7.             Middle East & Africa Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)

Table 8.             Middle East & Africa Glycomic Therapeutics Market, by Others– Revenue and Forecast to 2028 (USD Million)

Table 9.             Middle East & Africa Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)

Table 10.          Saudi Arabia Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Saudi Arabia Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Saudi Arabia Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Saudi Arabia Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Saudi Arabia Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Saudi Arabia Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Saudi Arabia Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Saudi Arabia Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)

Table 18.          UAE Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)

Table 19.          UAE Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)

Table 20.          UAE Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)

Table 21.          UAE Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)

Table 22.          UAE Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)

Table 23.          UAE Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)

Table 24.          UAE Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25.          UAE Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)

Table 26.          South Africa Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)

Table 27.          South Africa Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)

Table 28.          South Africa Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)

Table 29.          South Africa Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)

Table 30.          South Africa Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)

Table 31.          South Africa Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)

Table 32.          South Africa Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 33.          South Africa Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of MEA Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of MEA Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of MEA Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Rest of MEA Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)

Table 38.          Rest of MEA Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)

Table 39.          Rest of MEA Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)

Table 40.          Rest of MEA Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 41.          Rest of MEA Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)

Table 42.          Organic Developments in the Glycomic Therapeutics Market

Table 43.          Inorganic Developments in the Glycomic Therapeutics Market

Table 44.          Glossary of Terms in Glycomic Therapeutics Market

LIST OF FIGURES

Figure 1.           Middle East & Africa Glycomic Therapeutics Market Segmentation

Figure 2.           Middle East & Africa Glycomic Therapeutics Market, By Country

Figure 3.           Middle East & Africa Glycomic Therapeutics Market Overview

Figure 4.           Synthetic Segment Held Largest Share of Class Segment in Middle East & Africa Glycomic Therapeutics Market

Figure 5.           UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Middle East & Africa Glycomic Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East & Africa Glycomics market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Middle East & Africa Glycomic Therapeutics Market, by Class 2022 & 2028 (%)

Figure 10.        Middle East & Africa Isolated Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Middle East & Africa Synthetic - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Middle East & Africa Glycomics Market, by Indication 2022 & 2028 (%)

Figure 13.        Middle East & Africa Thrombosis and chemoprophylaxis Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Middle East & Africa Anaemia Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Middle East & Africa Anti-adhesive and Anti-inflammatory Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Middle East & Africa Cataract Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Middle East & Africa Gaucher’s diseases Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Middle East & Africa MPS-1 & IV Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Middle East & Africa Cancer Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Middle East & Africa Alzheimer's Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Middle East & Africa Influenza Type A and B Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Middle East & Africa Others Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Middle East & Africa Glycomic Therapeutics Market, by Structures 2022 & 2028 (%)

Figure 24.        Middle East & Africa Glycoproteins - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Middle East & Africa Targeting Sialic Acid - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Middle East & Africa Zanamivir - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Middle East & Africa Oseltamivir - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Middle East & Africa Proteoglycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Middle East & Africa Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Middle East & Africa Targeting Glycosaminoglycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Middle East & Africa Heparin - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        Middle East & Africa Hyaluronan (HA)- Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        Middle East & Africa Laronidase - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.        Middle East & Africa Galsulfase (Naglazyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        Middle East & Africa Hyaluronidase (Cumulase) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Middle East & Africa Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Middle East & Africa Targeting Glycosphingolipids - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Middle East & Africa Imiglucerase (Cerezyme - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Middle East & Africa Agalsidase (Fabrazyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        Middle East & Africa N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41.        Middle East & Africa Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        Middle East & Africa Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 43.        Middle East & Africa Acarbose - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        Middle East & Africa Alglucosidase Alfa (Myozyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        Middle East & Africa Allosamidin - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Middle East & Africa Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47.        Middle East & Africa Glycomic Therapeutics Market, by Mode of Action 2022 & 2028 (%)

Figure 48.        Middle East & Africa Inhibits Neuraminidase - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49.        Middle East & Africa Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50.        Middle East & Africa Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 51.        Middle East & Africa Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 52.        Middle East & Africa Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 53.        Middle East & Africa Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)

Figure 54.        Middle East & Africa Beta And Gamma Interferons - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 55.        Middle East & Africa Others - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 56.        Middle East & Africa Glycomic Therapeutics Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 57.        Middle East & Africa: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 58.        Saudi Arabia: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59.        UAE: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60.        South Africa: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61.        Rest of MEA: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62.        Growth Strategies in the Glycomic Therapeutics Market (%)